DK1091734T3 - Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde - Google Patents

Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde

Info

Publication number
DK1091734T3
DK1091734T3 DK99930683T DK99930683T DK1091734T3 DK 1091734 T3 DK1091734 T3 DK 1091734T3 DK 99930683 T DK99930683 T DK 99930683T DK 99930683 T DK99930683 T DK 99930683T DK 1091734 T3 DK1091734 T3 DK 1091734T3
Authority
DK
Denmark
Prior art keywords
mucosa
reducing
radiation therapy
harmful effects
animal skin
Prior art date
Application number
DK99930683T
Other languages
English (en)
Inventor
Deborah J Davenport
Kathy L Gross
Gregory K Ogilvie
Michael S Hand
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK1091734T3 publication Critical patent/DK1091734T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK99930683T 1998-06-29 1999-06-24 Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde DK1091734T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PCT/US1999/014344 WO2000000189A1 (en) 1998-06-29 1999-06-24 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Publications (1)

Publication Number Publication Date
DK1091734T3 true DK1091734T3 (da) 2004-01-26

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99930683T DK1091734T3 (da) 1998-06-29 1999-06-24 Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde

Country Status (17)

Country Link
US (1) US6015798A (da)
EP (1) EP1091734B1 (da)
JP (2) JP4860814B2 (da)
AR (1) AR019728A1 (da)
AT (1) ATE249821T1 (da)
AU (1) AU761266B2 (da)
BR (1) BR9911663A (da)
CA (1) CA2336628C (da)
DE (1) DE69911409T2 (da)
DK (1) DK1091734T3 (da)
ES (1) ES2207951T3 (da)
MX (1) MXPA01000152A (da)
NO (1) NO329910B1 (da)
NZ (1) NZ508766A (da)
TR (1) TR200100457T2 (da)
WO (1) WO2000000189A1 (da)
ZA (1) ZA200007650B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PE20010524A1 (es) * 1999-09-09 2001-05-23 Nestle Sa Composicion nutricional para animales domesticos que contiene una fuente de nutrientes con propiedades antioxidantes
WO2001082720A1 (en) * 2000-05-01 2001-11-08 The Iams Company Pet food composition for reducing inflammatory response in cats
JP2003534019A (ja) 2000-06-01 2003-11-18 ユナイテッド フィーズ，インコーポレーテッド 動物飼料および方法
ATE492166T1 (de) 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US20060204636A1 (en) * 2002-12-23 2006-09-14 Butterwick Richard F Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
DE602004015472D1 (de) * 2003-08-11 2008-09-11 Hills Pet Nutrition Inc Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
JP2007502805A (ja) * 2003-08-18 2007-02-15 ビーティージー・インターナショナル・リミテッド 神経変性状態の処置
DK2260718T3 (da) 2003-11-25 2014-11-17 Virginia Tech Intell Prop Sammensætning, som et dyr skal indtage, til anvendelse til reduktion af MAP-kinase-aktivitet
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
ES2579430T3 (es) 2004-12-30 2016-08-11 Hill's Pet Nutrition, Inc. Métodos para aumentar la calidad de vida de un animal en crecimiento
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
EP2214481B1 (en) 2007-10-15 2019-05-01 United Animal Health, Inc. Method for increasing performance of offspring
WO2009070589A1 (en) * 2007-11-30 2009-06-04 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
JP6001184B2 (ja) * 2012-11-15 2016-10-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 食餌のミネラル制限を介したヘアボール制御
JP2020507628A (ja) 2017-02-13 2020-03-12 ウィンターミュート バイオメディカル, インク.Wintermute Biomedical, Inc. 抗病原体治療組成物
CN113164420A (zh) 2018-10-01 2021-07-23 温特穆特生物医学公司 治疗组合物
CN114829630A (zh) * 2019-12-19 2022-07-29 希尔氏宠物营养品公司 用于评估和降低患上犬科动物甲状腺功能减退症和其它自身免疫性病状的风险的试剂、试剂盒和方法
WO2021126221A1 (en) 2019-12-19 2021-06-24 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Also Published As

Publication number Publication date
WO2000000189A1 (en) 2000-01-06
NO20006575D0 (no) 2000-12-21
NO20006575L (no) 2001-02-28
US6015798A (en) 2000-01-18
JP2009035533A (ja) 2009-02-19
AU761266B2 (en) 2003-05-29
NO329910B1 (no) 2011-01-24
JP5704791B2 (ja) 2015-04-22
ATE249821T1 (de) 2003-10-15
CA2336628C (en) 2009-03-24
EP1091734B1 (en) 2003-09-17
MXPA01000152A (es) 2002-10-17
AU4716799A (en) 2000-01-17
DE69911409T2 (de) 2004-07-08
ZA200007650B (en) 2002-08-28
JP4860814B2 (ja) 2012-01-25
NZ508766A (en) 2003-05-30
ES2207951T3 (es) 2004-06-01
EP1091734A1 (en) 2001-04-18
AR019728A1 (es) 2002-03-13
DE69911409D1 (de) 2003-10-23
BR9911663A (pt) 2005-12-20
TR200100457T2 (tr) 2001-08-21
CA2336628A1 (en) 2000-01-06
JP2002519320A (ja) 2002-07-02

Similar Documents

Publication Publication Date Title
DK1091734T3 (da) Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde
GB0118394D0 (en) Radiation treatment system and method
DK0881881T3 (da) Antiparasitært præparat til behandling og beskyttelse af kæledyr
DK1041879T4 (da) Desinfektionsmiddel og fremstillingsmetode
NO980687D0 (no) System og fremgangsmåte for perfusjon-hypertermibehandling
NO20000996D0 (no) Kombinasjonsterapi omfattende atorvastatin og et antihypertensivt middel
IS5525A (is) Innúðabúnaður og aðferð
DK1450891T3 (da) Afgivelsessystem til interstitiel stråleterapi og fremgangsmåde til fremstilling deraf
KR960008976A (ko) 처리장치 및 처리방법
DE69812725D1 (de) Laserbehandlungsgerät
NO991701D0 (no) HIV og cancer behandling
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
DK0961609T3 (da) Fremgangsmåde til forbedring af sundhedstilstanden af hår og hovedbund
DE60216970D1 (de) Implantierbare herzstimulationsvorrichtung sowie diese vorrichtung enthaltendes system
DE69828985D1 (de) Lichtgebender katheter sowie anwendungsverfahren
DE69907803D1 (de) Laserbehandlungsgerät
ID27483A (id) Metoda terapi gen
DE69937907D1 (de) Sprachkodiererprozessor und sprachkodierungsmethode
IT1313366B1 (it) Apparecchio e procedimento per allineare componenti
DE29713360U1 (de) Therapeutisches Laserbestrahlungsgerät
BR9507555A (pt) Agente de tratamento de pele térmico
PT102361B (pt) Metodo de obrencao de arileteres e tioeteres utilizando radiacao micro-ondas
DK0908135T3 (da) System, konstruktion, indretning og fremgangsmåde til overfladebehandling
IS6427A (is) Efnasamband og aðferð til að meðhöndla sársauka